Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;113(9):1991-2002.
doi: 10.1111/apa.17167. Epub 2024 Feb 23.

Faecal microbiota transplantation in children: A systematic review

Ella Lauwers  1 , João Sabino  2   3 , Ilse Hoffman  1 , Karen van Hoeve  1
Affiliations

Faecal microbiota transplantation in children: A systematic review

Ella Lauwers et al. Acta Paediatr. 2024 Sep.

Abstract

Aim: Novel technologies offer insights into the potential role of the intestinal microbiota in human health and disease. Dysbiosis has been associated with several diseases, and it is thought to play a role in the pathogenesis of different gastrointestinal diseases. Faecal microbiota transplantation (FMT) is emerging as a method to modulate the gastrointestinal microbial ecosystem. While recurrent Clostridioides difficile infection is the recognised FMT indication, exploration of other therapeutic uses is ongoing.

Methods: Following PRISMA guidelines, we conducted a systematic review, extracting 583 articles from Embase and PubMed (index date to October 2022).

Results: The search yielded 58 studies for full review, with 50 included in the systematic review. Articles were categorised by FMT indication, study design, efficacy, adverse events, donor selection and administration route. FMT appears safe and effective for recurrent Clostridioides difficile infection, although severe adverse events are reported in children. However, there are currently insufficient data to support the use of FMT for other potential therapeutic indications (such as irritable or inflammatory bowel disease or obesity), beside the potential to decolonise multi-drug resistant organisms.

Conclusion: This underscores the need for randomised, controlled, prospective cohort studies in children to assess FMT effectiveness in diverse conditions and counteract publication bias.

Keywords: children; clostridioides difficile; faecal microbiota transplantation; inflammatory bowel disease.

PubMed Disclaimer

References

REFERENCES

    1. Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392‐400.
    1. Gurram B, Sue P. Fecal microbiota transplantation in children: current concepts. Curr Opin Pediatr. 2019;31(5):623‐629.
    1. Fang H, Fu L, Wang J. Protocol for fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta‐analysis. Biomed Res Int. 2018;2018:8941340.
    1. Davidovics ZH, Michail S, Nicholson MR, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection and other conditions in children: a joint position paper from the north American Society for Pediatric Gastroenterology, Hepatology, and nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2019;68(1):130‐143.
    1. Fareed S, Sarode N, Stewart FJ, et al. Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children. PeerJ. 2018;6:e4663.

Publication types

LinkOut - more resources